Safety and efficacy of apixaban and rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation for secondary prevention of stroke of systemic embolism
Latest Information Update: 30 Jun 2017
At a glance
- Drugs Apixaban (Primary) ; Rivaroxaban (Primary) ; Warfarin
- Indications Embolism; Ischaemic stroke
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 30 Jun 2017 New trial record